Long-Term Debt: The sum of all long term debt fields.
Maze Therapeutics, Inc. (MAZE) Long-Term Debt data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-30.09M |
|
-- |
|
-- |
|
$32.97M |
|
$-32.97M |
|
$2.88M |
|
$-30.09M |
|
$-30.09M |
|
$-30.09M |
|
$-30.09M |
|
$-30.09M |
|
$-30.09M |
|
$-32.97M |
|
$-32.39M |
|
45.78M |
|
45.78M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$391.30M |
|
$5.54M |
|
$30.76M |
|
$422.06M |
|
$22.11M |
|
|
Long-Term Debt |
-- |
$20.51M |
|
$42.62M |
|
$379.44M |
|
$379.44M |
|
$379.44M |
|
48.08M |
|
| Cash Flow Statement Financials | |
$-84.21M |
|
$-67.58M |
|
$271.75M |
|
$197.90M |
|
$317.86M |
|
$119.96M |
|
$10.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-84.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.93% |
|
-7.93% |
|
-7.13% |
|
-7.93% |
|
$7.89 |
|
$-1.86 |
|
$-1.84 |
|